-+ 0.00%
-+ 0.00%
-+ 0.00%

Citizens Maintains Market Outperform on Zimmer Biomet Holdings, Lowers Price Target to $105

Benzinga·04/29/2026 15:55:42
Listen to the news
Citizens analyst David Turkaly maintains Zimmer Biomet Holdings (NYSE:ZBH) with a Market Outperform and lowers the price target from $120 to $105.